{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:27:50Z","timestamp":1793021270448,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A widely used method in assessing small bowel permeability is the lactulose:mannitol test, where the lactulose:mannitol ratio (LMR) is measured. However, there is discrepancy in how the test is conducted and in the values of LMR obtained across studies. This meta-analysis aims to determine LMR in healthy subjects, coeliac and Crohn\u2019s disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was performed using PRISMA guidance to identify studies assessing LMR in coeliac or Crohn\u2019s disease. 19 studies included in the meta-analysis measured gut permeability in coeliac disease, 17 studies in Crohn\u2019s disease. Outcomes of interest were LMR values and comparisons of standard mean difference (SMD) and weighted mean difference (WMD) in healthy controls, inactive Crohn\u2019s, active Crohn\u2019s, treated coeliac and untreated coeliac. Pooled estimates of differences in LMR were calculated using the random effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Pooled LMR in healthy controls was 0.014 (95% CI: 0.006\u20130.022) while pooled LMRs in untreated and treated coeliac were 0.133 (95% CI: 0.089\u20130.178) and 0.037 (95% CI: 0.019\u20130.055). In active and inactive Crohn\u2019s disease, pooled LMRs were 0.093 (95% CI: 0.031\u20130.156) and 0.028 (95% CI: 0.015\u20130.041). Significant differences were observed in LMR between: (1) healthy controls and treated coeliacs (SMD\u2009=\u20090.409 95% CI 0.034 to 0.783,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.032), (2) healthy controls and untreated coeliacs (SMD\u2009=\u20091.362 95% CI: 0.740 to 1.984,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), (3) treated coeliacs and untreated coeliacs (SMD\u2009=\u20090.722 95% CI: 0.286 to 1.157,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), (4) healthy controls and inactive Crohn\u2019s (SMD\u2009=\u20091.265 95% CI: 0.845 to 1.686,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), (5) healthy controls and active Crohn\u2019s (SMD\u2009=\u20092.868 95% CI: 2.112 to 3.623,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and (6) active Crohn\u2019s and inactive Crohn\u2019s (SMD\u2009=\u20091.429 (95% CI: 0.580 to 2.278,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). High heterogeneity was observed, which was attributed to variability in protocols used across different studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The use of gut permeability measurements in screening and monitoring of coeliac and Crohn\u2019s disease is promising. LMR is useful in performing this function with significant limitations. More robust alternative tests with higher degrees of clinical evidence are needed if measurements of gut permeability are to find widespread clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-021-02082-z","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T08:03:58Z","timestamp":1641801838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["A case for improved assessment of gut permeability: a meta-analysis quantifying the lactulose:mannitol ratio in coeliac and Crohn\u2019s disease"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7410-1902","authenticated-orcid":false,"given":"Jonathan","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarlet","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Teare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara","family":"Darzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hutan","family":"Ashrafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"issue":"3","key":"2082_CR1","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1172\/JCI76304","volume":"125","author":"EA Mayer","year":"2015","unstructured":"Mayer EA, Tillisch K, Gupta A. Gut\/brain axis and the microbiota. J Clin Investig. 2015;125(3):926\u201338.","journal-title":"J Clin Investig"},{"issue":"8","key":"2082_CR2","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68(8):1516\u201326.","journal-title":"Gut"},{"key":"2082_CR3","first-page":"71","volume":"6","author":"C Canavan","year":"2014","unstructured":"Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71.","journal-title":"Clin Epidemiol"},{"key":"2082_CR4","doi-asserted-by":"crossref","unstructured":"Sequeira IR, Lentle RG, Kruger MC, Hurst RD. Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability. PLoS ONE. 2014;9(6).","DOI":"10.1371\/journal.pone.0099256"},{"issue":"1\u20132","key":"2082_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jchromb.2006.02.050","volume":"834","author":"R Paroni","year":"2006","unstructured":"Paroni R, Fermo I, Molteni L, Folini L, Pastore MR, Mosca A, Bosi E. Lactulose and mannitol intestinal permeability detected by capillary electrophoresis. J Chromatogr B. 2006;834(1\u20132):183\u20137.","journal-title":"J Chromatogr B"},{"issue":"1","key":"2082_CR6","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1111\/j.1365-2982.2009.01361.x","volume":"22","author":"M Camilleri","year":"2010","unstructured":"Camilleri M, Nadeau A, Lamsam J, Linker Nord S, Ryks M, Burton D, Sweetser S, Zinsmeister AR, Singh R. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motil. 2010;22(1):e15-26.","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"2082_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0009-8981(85)90300-6","volume":"148","author":"I Cobden","year":"1985","unstructured":"Cobden I, Hamilton I, Rothwell J, Axon AT. Cellobiose\/mannitol test: physiological properties of probe molecules and influence of extraneous factors. Clin Chim Acta. 1985;148(1):53\u201362.","journal-title":"Clin Chim Acta"},{"key":"2082_CR8","first-page":"527","volume-title":"Intestinal absorption and secretion","author":"IS Menzies","year":"1984","unstructured":"Menzies IS. Transmucosal passage of inert molecules in health and disease. In: Skadhauge E, Heintze K, editors. Intestinal absorption and secretion. Lancaster: MTP Press; 1984. p. 527\u201343."},{"issue":"suppl_4","key":"2082_CR9","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1093\/cid\/ciu541","volume":"59","author":"DM Denno","year":"2014","unstructured":"Denno DM, VanBuskirk K, Nelson ZC, Musser CA, Hay Burgess DC, Tarr PI. Use of the lactulose to mannitol ratio to evaluate childhood environmental enteric dysfunction: a systematic review. Clin Infect Dis. 2014;59(suppl_4):S213\u20139.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2082_CR10","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3109\/00365529708996538","volume":"32","author":"L Blomquist","year":"1997","unstructured":"Blomquist L, Bark T, Hedenborg G, Norman A. Evaluation of the lactulose\/mannitol and 51Cr-ethylenediaminetetraacetic acid\/14C-mannitol methods for intestinal permeability: influence of urinary volume, sex, age, smoking, and intestinal disease on marker excretion. Scand J Gastroenterol. 1997;32(8):805\u201312.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"2082_CR11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336\u201341.","journal-title":"Int J Surg"},{"key":"2082_CR12","doi-asserted-by":"crossref","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366.","DOI":"10.1136\/bmj.l4898"},{"key":"2082_CR13","doi-asserted-by":"crossref","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","DOI":"10.1136\/bmj.i4919"},{"key":"2082_CR14","unstructured":"https:\/\/training.cochrane.org\/handbook\/current\/chapter-25."},{"issue":"9","key":"2082_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"7121","key":"2082_CR16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315(7121):1533\u20137.","journal-title":"BMJ"},{"issue":"2","key":"2082_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/SLA.0000000000001897","volume":"265","author":"ER St John","year":"2017","unstructured":"St John ER, Al-Khudairi R, Ashrafian H, Athanasiou T, Takats Z, Hadjiminas DJ, Darzi A, Leff DR. Diagnostic accuracy of intraoperative techniques for margin assessment in breast cancer surgery. Ann Surg. 2017;265(2):300\u201310.","journal-title":"Ann Surg"},{"issue":"8","key":"2082_CR18","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/clinchem\/44.8.1685","volume":"44","author":"R Marsilio","year":"1998","unstructured":"Marsilio R, D\u2019Antiga L, Zancan L, Dussini N, Zacchello F. Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clin Chem. 1998;44(8):1685\u201391.","journal-title":"Clin Chem"},{"issue":"12","key":"2082_CR19","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1590\/S0100-879X2008001200010","volume":"41","author":"EG Vilela","year":"2008","unstructured":"Vilela EG, Torres HO, Ferrari ML, Lima AS, Cunha AS. Gut permeability to lactulose and mannitol differs in treated Crohn\u2019s disease and celiac disease patients and healthy subjects. Braz J Med Biol Res. 2008;41(12):1105\u20139.","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"2082_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/00054725-200105000-00003","volume":"7","author":"GC Sturniolo","year":"2001","unstructured":"Sturniolo GC, Di Leo V, Ferronato A, D\u2019Odorico A, D\u2019Inc\u00e0 R. Zinc supplementation tightens \u201cleaky gut\u201d in Crohn\u2019s disease. Inflamm Bowel Dis. 2001;7(2):94\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"2082_CR21","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s10620-007-0184-8","volume":"53","author":"M Dastych","year":"2008","unstructured":"Dastych M, Novotn\u00e1 H, \u010c\u00edhalov\u00e1 J. Lactulose\/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn\u2019s disease. Dig Dis Sci. 2008;53(10):2789\u201392.","journal-title":"Dig Dis Sci"},{"key":"2082_CR22","doi-asserted-by":"crossref","unstructured":"D'inc\u00e0 R, Annese V, Di Leo V, Latiano A, Quaino V, Abazia C, Vettorato MG, Sturniolo GC. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. Aliment. Pharmacol. Therap. 2006;23(10):1455\u201361.","DOI":"10.1111\/j.1365-2036.2006.02916.x"},{"issue":"3","key":"2082_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/gut.2005.065557","volume":"55","author":"S Buhner","year":"2006","unstructured":"Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, Kuechler I, Krueger S, Schmidt HH, Lochs H. Genetic basis for increased intestinal permeability in families with Crohn\u2019s disease: role of CARD15 3020insC mutation? Gut. 2006;55(3):342\u20137.","journal-title":"Gut"},{"issue":"10","key":"2082_CR24","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1111\/j.1572-0241.1999.01444.x","volume":"94","author":"R D\u2019Inc\u00e0","year":"1999","unstructured":"D\u2019Inc\u00e0 R, Di Leo V, Corrao G, Martines D, D\u2019Odorico A, Mestriner C, Venturi C, Longo G, Sturniolo GC. Intestinal permeability test as a predictor of clinical course in Crohn\u2019s disease. Am J Gastroenterol. 1999;94(10):2956\u201360.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2082_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000329403","volume":"84","author":"GR Swanson","year":"2011","unstructured":"Swanson GR, Tieu V, Shaikh M, Forsyth C, Keshavarzian A. Is moderate red wine consumption safe in inactive inflammatory bowel disease? Digestion. 2011;84(3):238\u201344.","journal-title":"Digestion"},{"issue":"3","key":"2082_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1046\/j.1365-2036.2003.01611.x","volume":"18","author":"GE Wild","year":"2003","unstructured":"Wild GE, Waschke KA, Bitton A, Thomson AB. The mechanisms of prednisone inhibition of inflammation in Crohn\u2019s disease involve changes in intestinal permeability, mucosal TNF\u03b1 production and nuclear factor kappa B expression. Aliment Pharmacol Ther. 2003;18(3):309\u201317.","journal-title":"Aliment Pharmacol Ther"},{"key":"2082_CR27","doi-asserted-by":"crossref","unstructured":"Garcia Vilela E, De Lourdes De Abreu Ferrari M, Oswaldo Da Gama Torres H, Guerra Pinto A, Carolina Carneiro Aguirre A, Paiva Martins F, Marcos Andrade Goulart E, Sales Da Cunha A. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand J Gastroenterol. 2008;43(7):842\u20138.","DOI":"10.1080\/00365520801943354"},{"issue":"10","key":"2082_CR28","first-page":"587","volume":"27","author":"DL Sigalet","year":"2013","unstructured":"Sigalet DL, Kravarusic D, Butzner D, Hartmann B, Holst JJ, Meddings J. A pilot study examining the relationship among Crohn disease activity, glucagon-like peptide-2 signalling and intestinal function in pediatric patients. Can J Gastroenterol Hepatol. 2013;27(10):587\u201392.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"2082_CR29","first-page":"31","volume":"13","author":"SA Zamora","year":"1999","unstructured":"Zamora SA, Hilsden RJ, Meddings JB, Butzner JD, Scott RB, Sutherland LR. Intestinal permeability before and after ibuprofen in families of children with Crohn\u2019s disease. Can J Gastroenterol Hepatol. 1999;13(1):31\u20137.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"4","key":"2082_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/gut.29.4.511","volume":"29","author":"F Andre","year":"1988","unstructured":"Andre F, Andre C, Emery Y, Forichon J, Descos L, Minaire Y. Assessment of the lactulose-mannitol test in Crohn\u2019s disease. Gut. 1988;29(4):511\u20135.","journal-title":"Gut"},{"issue":"4","key":"2082_CR31","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1007\/s10620-011-1947-9","volume":"57","author":"J Benjamin","year":"2012","unstructured":"Benjamin J, Makharia G, Ahuja V, Rajan KA, Kalaivani M, Gupta SD, Joshi YK. Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn\u2019s disease: a randomized controlled trial. Dig Dis Sci. 2012;57(4):1000\u201312.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"2082_CR32","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1111\/j.1572-0241.2001.04684.x","volume":"96","author":"NP Breslin","year":"2001","unstructured":"Breslin NP, Nash C, Hilsden RJ, Hershfield NB, Price LM, Meddings JB, Sutherland LR. Intestinal permeability is increased in a proportion of spouses of patients with Crohn\u2019s disease. Am J Gastroenterol. 2001;96(10):2934\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2082_CR33","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1053\/gast.1996.v110.pm8613043","volume":"110","author":"RJ Hilsden","year":"1996","unstructured":"Hilsden RJ, Meddings JB, Sutherland LR. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn\u2019s disease. Gastroenterology. 1996;110(5):1395\u2013403.","journal-title":"Gastroenterology"},{"issue":"3","key":"2082_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00042737-199903000-00012","volume":"11","author":"G Novacek","year":"1999","unstructured":"Novacek G, Miehsler W, Wrba F, Ferenci P, Penner E, Vogelsang H. Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol. 1999;11(3):283\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"2082_CR35","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1046\/j.1365-2036.2001.01034.x","volume":"15","author":"H Vogelsang","year":"2001","unstructured":"Vogelsang H, Schwarzenhofer M, Steiner B, Wyatt J, Oberhuber G. In vivo and in vitro permeability in coeliac disease. Aliment Pharmacol Ther. 2001;15(9):1417\u201325.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"2082_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0261-5614(91)90091-P","volume":"10","author":"M Elia","year":"1991","unstructured":"Elia M, Northrop-Clewes CA, Lunn PG, Goren A. Intestinal permeability in man: effects of acute systemic infections. Clin Nutr. 1991;10(2):76\u201380.","journal-title":"Clin Nutr"},{"issue":"2","key":"2082_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00005176-199602000-00012","volume":"22","author":"M Kuitunen","year":"1996","unstructured":"Kuitunen M, Savilahti E. Gut permeability to human \u03b1-lactalbumin, \u03b2-lactoglobulin, mannitol, and lactulose in celiac disease. J Pediatr Gastroenterol Nutr. 1996;22(2):197\u2013204.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"2082_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00004836-198506000-00009","volume":"7","author":"SO Ukabam","year":"1985","unstructured":"Ukabam SO, Cooper BT. Small intestinal permeability as an indicator of jejunal mucosal recovery in patients with celiac sprue on a gluten-free diet. J Clin Gastroenterol. 1985;7(3):232\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"02","key":"2082_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0028-1103484","volume":"41","author":"AK Vecsei","year":"2009","unstructured":"Vecsei AK, Graf UB, Vogelsang H. Follow-up of adult celiac patients: which noninvasive test reflects mucosal status most reliably? Endoscopy. 2009;41(02):123\u20138.","journal-title":"Endoscopy"},{"issue":"4","key":"2082_CR40","first-page":"512","volume":"37","author":"SD Johnston","year":"2000","unstructured":"Johnston SD, Smye M, Watson RP, McMillan SA, Trimble ER, Love AG. Lactulose-mannitol intestinal permeability test: a useful screening test for adult coeliac disease. Ann Clin Biochem. 2000;37(4):512\u20139.","journal-title":"Ann Clin Biochem"},{"issue":"5","key":"2082_CR41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/00005176-198709000-00006","volume":"6","author":"I Hamilton","year":"1987","unstructured":"Hamilton I, Hill A, Bose B, Bouchier IA, Forsyth JS. Small intestinal permeability in pediatric clinical practice. J Pediatr Gastroenterol Nutr. 1987;6(5):697\u2013701.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"2082_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/gut.40.2.215","volume":"40","author":"C Catassi","year":"1997","unstructured":"Catassi C, Fabiani E, R\u00e4tsch IM, Bonucci A, Dotti M, Coppa GV, Giorgi PL. Is the sugar intestinal permeability test a reliable investigation for coeliac disease screening? Gut. 1997;40(2):215\u20137.","journal-title":"Gut"},{"issue":"3","key":"2082_CR43","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/gut.34.3.354","volume":"34","author":"RM Van Elburg","year":"1993","unstructured":"Van Elburg RM, Uil JJ, Mulder CJ, Heymans HS. Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut. 1993;34(3):354\u20137.","journal-title":"Gut"},{"key":"2082_CR44","doi-asserted-by":"crossref","unstructured":"Rajani S, Huynh HQ, Shirton L, Kluthe C, Spady D, Prosser C, Meddings J, Rempel GR, Persad R, Turner JM. A Canadian study toward changing local practice in the diagnosis of pediatric celiac disease. Can J Gastroenterol Hepatol. 2016;2016.","DOI":"10.1155\/2016\/6234160"},{"issue":"12","key":"2082_CR45","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1111\/j.1572-0241.1999.01645.x","volume":"94","author":"E Smecuol","year":"1999","unstructured":"Smecuol E, Vazquez H, Sugai E, Niveloni S, Pedreira S, Cabanne A, Fiorini A, Kogan Z, Mauri\u00f1o E, Meddings J, Bai JC. Sugar tests detect celiac disease among first-degree relatives. Am J Gastroenterol. 1999;94(12):3547\u201352.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"2082_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1542-3565(04)00778-5","volume":"3","author":"E Smecuol","year":"2005","unstructured":"Smecuol E, Sugai E, Niveloni S, V\u00e1zquez H, Pedreira S, Mazure R, Moreno ML, Label M, Mauri\u00f1o E, Fasano A, Meddings J. Permeability, zonulin production, and enteropathy in dermatitis herpetiformis. Clin Gastroenterol Hepatol. 2005;3(4):335\u201341.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"2082_CR47","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.3390\/nu5114653","volume":"5","author":"S Gatti","year":"2013","unstructured":"Gatti S, Caporelli N, Galeazzi T, Francavilla R, Barbato M, Roggero P, Malamisura B, Iacono G, Budelli A, Gesuita R, Catassi C. Oats in the diet of children with celiac disease: preliminary results of a double-blind, randomized, placebo-controlled multicenter Italian study. Nutrients. 2013;5(11):4653\u201364.","journal-title":"Nutrients"},{"issue":"4","key":"2082_CR48","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0016-5085(97)70123-9","volume":"112","author":"ED Smecuol","year":"1997","unstructured":"Smecuol ED, Bai JC, Vazquez HO, Kogan ZU, Cabanne A, Niveloni SO, Pedreira SI, Boerr LU, Maurino ED, Meddings JB. Gastrointestinal permeability in celiac disease. Gastroenterology. 1997;112(4):1129\u201336.","journal-title":"Gastroenterology"},{"issue":"2","key":"2082_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MCG.0b013e31827759ac","volume":"47","author":"E Smecuol","year":"2013","unstructured":"Smecuol E, Hwang HJ, Sugai E, Corso L, Chernavsky AC, Bellavite FP, Gonz\u00e1lez A, Vod\u00e1novich F, Moreno ML, V\u00e1zquez H, Lozano G. Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease. J Clin Gastroenterol. 2013;47(2):139\u201347.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"2082_CR50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00054725-199905000-00003","volume":"5","author":"RJ Hilsden","year":"1999","unstructured":"Hilsden RJ, Meddings JB, Hardin J, Gall GD, Sutherland LR. Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn\u2019s disease relapse. Inflamm Bowel Dis. 1999;5(2):85\u201391.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"2082_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0016-5085(89)90767-1","volume":"96","author":"LD Juby","year":"1989","unstructured":"Juby LD, Rothwell J, Axon AT. Lactulose\/mannitol test: an ideal screen for celiac disease. Gastroenterology. 1989;96(1):79\u201385.","journal-title":"Gastroenterology"},{"key":"2082_CR52","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors).\u00a0Cochrane Handbook for Systematic Reviews of Interventions\u00a0version 6.1\u00a0(updated September 2020). Cochrane. 2020. www.training.cochrane.org\/handbook.","DOI":"10.1002\/9781119536604"},{"issue":"1","key":"2082_CR53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.","journal-title":"BMC Med Res Methodol"},{"key":"2082_CR54","doi-asserted-by":"crossref","unstructured":"Musa MA, Mamun Kabir M, Hossain I, Ahmed E, Siddique A, Rashid H, Mahfuz M, Mondal D, Ahmed T, Petri WA, Haque R. Measurement of intestinal permeability using lactulose and mannitol with conventional five hours and shortened two hours urine collection by two different methods: HPAE-PAD and LC-MSMS. PLoS ONE. 2019;14(8).","DOI":"10.1371\/journal.pone.0220397"},{"issue":"9","key":"2082_CR55","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1023\/A:1018826307489","volume":"43","author":"S Akram","year":"1998","unstructured":"Akram S, Mourani S, Ou CN, Rognerud C, Sadiq R, Goodgame RW. Assessment of intestinal permeability with a two-hour urine collection. Dig Dis Sci. 1998;43(9):1946\u201350.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"2082_CR56","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/MPG.0000000000000459","volume":"59","author":"GO Lee","year":"2014","unstructured":"Lee GO, Kosek P, Lima AA, Singh R, Yori PP, Olortegui MP, Lamsam JL, Oliveira DB, Guerrant RL, Kosek M. Lactulose: mannitol diagnostic test by HPLC and LC-MSMS platforms: considerations for field studies of intestinal barrier function and environmental enteropathy. J Pediatr Gastroenterol Nutr. 2014;59(4):544.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"2082_CR57","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0016-5085(03)01049-7","volume":"125","author":"T Matysiak-Budnik","year":"2003","unstructured":"Matysiak-Budnik T, Candalh C, Dugave C, Namane A, Cellier C, Cerf-Bensussan N, Heyman M. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology. 2003;125(3):696\u2013707.","journal-title":"Gastroenterology"},{"issue":"6","key":"2082_CR58","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/gut.37.6.777","volume":"37","author":"JD Schulzke","year":"1995","unstructured":"Schulzke JD, Schulzke I, Fromm M, Riecken EO. Epithelial barrier and ion transport in coeliac sprue: electrical measurements on intestinal aspiration biopsy specimens. Gut. 1995;37(6):777\u201382.","journal-title":"Gut"},{"issue":"8","key":"2082_CR59","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1096\/fj.04-3260com","volume":"19","author":"M Bruewer","year":"2005","unstructured":"Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA, Nusrat A. Interferon-\u03b3 induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J. 2005;19(8):923\u201333.","journal-title":"FASEB J"},{"issue":"4","key":"2082_CR60","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/00365520500235334","volume":"41","author":"S Drago","year":"2006","unstructured":"Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Sapone AT, Thakar M, Iacono G, Carroccio A, D\u2019Agate C, Not T, Zampini L. Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol. 2006;41(4):408\u201319.","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"2082_CR61","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/gutjnl-2011-300327","volume":"61","author":"M Heyman","year":"2012","unstructured":"Heyman M, Abed J, Lebreton C, Cerf-Bensussan N. Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Gut. 2012;61(9):1355\u201364.","journal-title":"Gut"},{"issue":"4","key":"2082_CR62","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1042\/CS20000193","volume":"100","author":"AG Cummins","year":"2001","unstructured":"Cummins AG, Thompson FM, Butler RN, Cassidy JC, Gillis D, Lorenzetti M, Southcott EK, Wilson PC. Improvement in intestinal permeability precedes morphometric recovery of the small intestine in coeliac disease. Clin Sci. 2001;100(4):379\u201386.","journal-title":"Clin Sci"},{"issue":"4","key":"2082_CR63","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s10620-009-0813-5","volume":"55","author":"DR Duerksen","year":"2010","unstructured":"Duerksen DR, Wilhelm-Boyles C, Veitch R, Kryszak D, Parry DM. A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig Dis Sci. 2010;55(4):1026\u201331.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2082_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"P Xu","year":"2019","unstructured":"Xu P, Elamin E, Elizalde M, Bours PP, Pierik MJ, Masclee AA, Jonkers DM. Modulation of intestinal epithelial permeability by plasma from patients with Crohn\u2019s Disease in a three-dimensional cell culture model. Sci Rep. 2019;9(1):1\u20131.","journal-title":"Sci Rep"},{"issue":"5","key":"2082_CR65","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/gutjnl-2012-304066","volume":"63","author":"M Vivinus-Nebot","year":"2014","unstructured":"Vivinus-Nebot M, Frin-Mathy G, Bzioueche H, Dainese R, Bernard G, Anty R, Filippi J, Saint-Paul MC, Tulic MK, Verhasselt V, Hebuterne X. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut. 2014;63(5):744\u201352.","journal-title":"Gut"},{"key":"2082_CR66","doi-asserted-by":"crossref","unstructured":"von Martels JZ, Bourgonje AR, Harmsen HJ, Faber KN, Dijkstra G. Assessing intestinal permeability in Crohn\u2019s disease patients using orally administered 52Cr-EDTA. PLoS ONE. 2019;14(2).","DOI":"10.1371\/journal.pone.0211973"},{"key":"2082_CR67","doi-asserted-by":"crossref","unstructured":"Fasano A. All disease begins in the (leaky) gut: Role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Research. 2020;9.","DOI":"10.12688\/f1000research.20510.1"},{"issue":"1","key":"2082_CR68","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12876-019-1002-4","volume":"19","author":"A Thomson","year":"2019","unstructured":"Thomson A, Smart K, Somerville MS, Lauder SN, Appanna G, Horwood J, Raj LS, Srivastava B, Durai D, Scurr MJ, Keita \u00c5V. The Ussing chamber system for measuring intestinal permeability in health and disease. BMC Gastroenterol. 2019;19(1):98.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"2082_CR69","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/apa.13747","volume":"106","author":"T Sundqvist","year":"2017","unstructured":"Sundqvist T, Stenhammar L, Tjellstr\u00f6m B, Magnusson KE, Forslund T, H\u00f6gberg L. Oral immunoglobulin treatment improved intestinal permeability in children with active Crohn\u2019s disease. Acta Paediatr. 2017;106(4):647\u201353.","journal-title":"Acta Paediatr"},{"key":"2082_CR70","doi-asserted-by":"crossref","unstructured":"Kosek M, Guerrant RL, Kang G, Bhutta Z, Yori PP, Gratz J, Gottlieb M, Lang D, Lee G, Haque R, Mason CJ. Assessment of environmental enteropathy in the MAL-ED cohort study: theoretical and analytic framework. Clin Infect Dis. 2014;59(suppl_4):S239\u201347.","DOI":"10.1093\/cid\/ciu457"},{"issue":"8","key":"2082_CR71","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1177\/1535370218768508","volume":"243","author":"MI Ordiz","year":"2018","unstructured":"Ordiz MI, Davitt C, Stephenson K, Agapova S, Divala O, Shaikh N, Manary MJ. EB 2017 Article: Interpretation of the lactulose: mannitol test in rural Malawian children at risk for perturbations in intestinal permeability. Exp Biol Med. 2018;243(8):677\u201383.","journal-title":"Exp Biol Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-02082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-021-02082-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-02082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T11:17:54Z","timestamp":1700047074000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-021-02082-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2082"],"URL":"https:\/\/doi.org\/10.1186\/s12876-021-02082-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-257838\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof Darzi is the Chair of the Health Security Initiative at Flagship Pioneering UK Ltd. However, there is no specific conflict of interest in this project itself.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}